INVESTIGATIONS ON IMMUNOMODULATORY EFFECT OF WHITE BUTTON MUSHROOM MEDICINAL PROPERTIES AGAINST COVID-19

Vol. 6 Issue 2 Page No-32-51

Satish Kumar Sinha, Tarun Kumar Upadhyay*, Sushil Kumar Sharma

School of Agriculture, Suresh Gyan Vihar University, Jaipur, Rajasthan, 302017, India

Abstract

The wave of a novel coronavirus is the source of (SARS) severe acute respirational syndrome was completely remarkable, but perhaps not surprising. The family of viruses over the previous thirty years is acquainted with several of the features of CoVs biology, pathogenesis, and disease that manifested so dramatically in the worldwide SARS epidemic. COVID -19 of coronavirus infections occurred in Wuhan, (China) since December 2019 and shortly spread to nearly all parts of the world. The main objective of this review is to find out the source of medicinal properties of A. bisporus (WBM) to enhanced immunodeficiency and cure COVID -2019. WBM is a very significant normal source of nourishment and medicine. Apart from this white button mushroom additionally has against immunomodulatory, antimicrobial, antifungal, inflammatory, anticancer, antioxidant and hostile to atherosclerotic properties. Agaricus bisporus belongs to the epigenous Basidiomycetes family and additionally the utmost major commercially cultivated mushroom inside in the biosphere. WBM rich in nutrients like vitamins, minerals, proteins, carbohydrates, lipids and fibres. Moreover, the content of few active ingredients, like lectins, polysaccharides, peptides, lipopolysaccharides, vital essential amino acids, glycoproteins, nucleosides, triterpenoids, fatty acids and their by-products, present in WBM. This review relies on this current data and data published within in the medicinal and dietetic quality of WBM. To grant evidence to proliferation immunodeficiency, this reviewed an ancient classics used of mushroom as source of medicine might be helpful to combat against novel coronavirus. The wide spread of  novel COVID-19,the proof of therapy for the severe acute respirational syndrome (SARS) and prevention programs issued by various health authority worldwide.

KEYWORDS:

WBM,

Medicinal properties,

immunodeficiency,

SARS,

COVID-19

INTRODUCTION

Agaricus bisporus could be a good source of trace elements like sodium, potassium, phosphorus, associated antioxidants and unsaturated fatty acid. It can inhibit aromatase, and therefore may be ready to lower the estrogen levels inside the human body, which could reduce carcinoma breast cancer susceptibility [43, 84]. Vitamin C and phenols compounds are common antioxidants in WBM. Ascorbic acid, flavonoid, carotenoids, and phenol, concentrations contained within the Agaricus sp. In WBM phenol as a major antioxidant were present in the extracts. WBM extraction of little particle exerting directly cytotoxicity concerning antioxidant compounds like phenol and flavonoids have confirmed that chemotherapy brought about apoptosis and successive phagocytosis of cancer cells rely on the redox repute and therefore the intracellular balance between seasoned and antioxidants [6].

The phenolic compound like Ergo sterol, extracted from WBM showed inhibitory influence on breast carcinoma most cancers cellular line in vitro via aromatase inhibition without side effect [14].The multiple respiratory diseases varying severity, including bronchiolitis, normal cold and pneumonia represent the Human coronaviruses (HCoVs) which are the main group of coronaviruses (CoVs). Present, six known HCoVs are identified, namely, HCoV-NL63, HCoV-HKU1, HCoV-OC43, HCoV-229E, severe acute respirational syndrome coronavirus (SARS-CoV)  and Middle East respirational syndrome coronavirus (MERS-CoV)  of which, four HCoV-NL63, HCoVs (HCoV-229E, HCoV-OC43, and HCoV-HKU1) are globally spread within in the human population and contribute to about one-third of normal cold infections in humans [44,79].

In Guangdong, China SARS-CoV first emerged in 2002–2003 as unusual pneumonia marked by fever, headache and subsequent onset of respiratory symptoms like cough and pneumonia, which can be advanced grow into life-lethal respiratory failure and acute breathing distress syndrome [29].

MERS-CoV reported cases frequently stem from outbursts within the centre of Middle Eastern countries or recent travel to the area [59]. Corona virus disease (COVID-19) is an infectious disease because of a newly discovered coronavirus. It is an enveloped by RNA viruses beneath the Coronaviridae family. Organized with Roniviridae, Artierivirdae and Coronaviridae are categorized below the Nidovirale order [51]. As anticipated through the global  Committee for Taxonomy of Viruses, Co-Vs are similarly categorized into four predominant genera, α (Alpha), β (Beta), ƴ (Gamma) and (δ) Delta coronaviruses based on categorization comparisons of whole viral genomes [27,52]. These Co-Vs can contaminate like avian, swine, and people as an extensive range of hosts. HCoVs are regarded to be both within inside the Alpha or Beta coronavirus genera, together withα- coronaviruses, HCoV-229E and HCoV-NL63, and β-coronaviruses, HCoV-HKU1, SARS-CoV, MERS-CoV and HCoV-OC43 as shown in (Table 1).

There’s a hip record of the usage of traditional herbal components to cure the parasitic disorders, like malaria fever. Olden day’s mushrooms are utilized for luxurious dietetic meals and therapeutic cause [53]. Agaricus blazei mushroom used as very well-known food and extensive medicinal drug [21].A. Blazei contained bioactive mixtures and acts as an antioxidant and as immunomodulatory mediators [7, 75].

There is increased interest in these compounds in numerous disease states, like cancer [34, 49], allergy [20, 34], inflammatory diseases [22], viral and bacterial infections, diabetes and IDL cholesterol biosynthesis [48, 60]. Furthermore, this mushroom use for the treatment of leishmaniasis and determined a very significant result [77, 78]. The utilization of WBM mushroom can be evaluated for the remedy of COVID-19.

Antiviral activity on Herpes Simplex Virus type 1(HSV1) studied with 50µg/ml of Agaricus blazei extract. The extract turned into a more positive significance to HSV1 [10]. The sulphated polysaccharide from Sargassum patens in opposition to herpes simplex virus type 2 study for the antiviral property[17, 90].

Table 1. Classification of human coronavirus (Source: www.nih.gov/coronavirus)

Coronaviriniae Genera Strains Discovery Host References
Alpha-coronavirus HCoV-229E 1966 Bats [52,63, 81]
HCoV-NL63 2004 Palm Civets, Bats [37, 52]
 

 

Beta-coronavirus

HCoV-OC43 1967 Cattle [79, 82]
HCoV-HKU1 2005 Mice [1,28]
SARS-CoV 2003 Palm Civets, Bats [2,52,85]
MERS-CoV 2012 Bats, Camels [36,38]
COVID-19 2019 Bats [88]

 

Table 2. List of Drug for treatment underlying clinical trial, COVID-19

Sr.No Drug Interventions Country Sr.No

 

 

Drug Interventions Country
1 Drug: BCG Vaccine Australia 32 Drug: Hydroxychloroquine India
2 Drug: Ceftriaxone Australia 33 Drug: Deferoxamine Iran
3 Drug: Fixed-duration Hydrocortisone Australia 34 Drug: Calcium Channel Blockers Ireland
4 Drug: Placebo Australia 35 Drug: Thiazide or Thiazide-like diuretics Ireland
5 Drug: Sargramostim Belgium 36 Drug: Piclidenoson Israel
6 Drug: Siltuximab Belgium 37 Drug: Tocilizumab Injection Italy
7 Drug: Tocilizumab Belgium 38 Drug: Tofacitinib Italy
8 Drug: Hydroxychloroquine + azithromycin Brazil 39 Other: Hyper immune plasma Italy
9 Drug: Remdesivir California 40 Drug: Aspirin 75mg NA
10 Drug: Azithromycin Canada 41 Drug: Azithromycin Tablets NA
11 Drug: Colchicine Canada 42 Drug: Clopidogrel 75mg NA
12 Drug: Hydroxychloroquine sulfate Canada 43 Drug: Eculizumab NA
13 Drug: Lopinavir/ritonavir Canada 44 Drug: Ibuprofen NA
14 Drug: Vitamin C Canada 45 Drug: Rivaroxaban 2.5 MG NA
15 Drug: Favipiravir China 46 Dietary Supplement: Glucose tablets Pakistan
16 Drug: Remdesivir placebo China 47 Drug: Azithromycin 500Mg Oral Tablet Pakistan
17 Drug: Ribavirin China 48 Drug: Hydroxychloroquine 200 Mg Oral Tablet Pakistan
18 Drug: Ritonavir+Oseltamivir China 49 Dietary Supplement: Vitamin D Spain
19 Drug: Tetrandrine China 50 Drug: Placebo: Hydroxychloroquine Spain
20 Drug: thymosin alpha 1 China 51 Drug: Placebos Spain
21 Drug: γ-Globulin China 52 Drug: Tocilizumab (TCZ) Switzerland
22 Drug: Bevacizumab Injection China 53 Drug: High dose vitamin C Turkey
23 Drug: Plasma Colombia 54 Drug: Plaquenil 200Mg Tablet Turkey
24 Drug: Camostat Mesylate Denmark 55 Combination Product: Hydroxychloroquine Sulfate + Azithromycin US
25 Drug: Kevzarasc Denmark 56 Dietary Supplement: Zinc US
26 Drug: RoActemra iv Denmark 57 Drug: Ascorbic Acid US
27 Drug: Interferon Beta-1A France 58 Drug: Losartan US
28 Drug: Lopinavir and ritonavir France 59 Drug: Nitric Oxide US
29 Drug: Nivolumab France 60 Drug: Nitric Oxide Gas US
30 Drug: Placebo of Hydroxychloroquine France  

61

 

Drug: Chloroquine phosphate

Vietnam
31 Other: NaCl 0.9% France

Table 3. Carbohydrate Compounds on Fresh

Components Contents
Total Sugar 4.5
Fructose 2.62
Mannitol 23.62
Trehalose (%) DW 1-3
β-glucans 8.6
Chitin 9.6

Table 4. Amino acid content on Dry Weight basis of (WBM) White Button Mushroom mg/g

 

Sr.No

Essential Amino Acid Chemical Formula  

        Other Name

                 Content mg/gm  

 

Mean

 

 

S.D±

Hays,1976

[33]

Sudheep etal,2014

[74]

Cherno

etal,

2016

[15]

Muszyńska,et al,2017

[55]

1 Histidine (H) C6H9N3O2 2-Amino-3-(1H-imidazole-4-yl) propanoic acid 0.64 1.5 2.7 14.1 4.73 5.46
2 Isoleucine(I) C6H13NO2 (2S,3S)-2-amino-3-methylpentanoic acid 1.28 2.3 3.6 1.0 2.04 1.02
3 Leucine(L) C6H13NO2 2-Amino-4-methylpentanoic acid 2.16 7.3 7.25 0.8 4.39 2.95
4 Lysine(K) C₆H₁₄N₂O₂ (2S)-2,6-Diaminohexanoic acid (L-lysine) 1.62 4.5 3.7 3.5 3.33 1.06
5 Methionine(M) C₅H₁₁NO₂S 2-amino-4-(methylthio)butanoic acid  

0.39

 

1.7

 

2.9

 

0.8

 

1.44

 

0.96

6 Phenylalanine(F) C9H11NO2 (S)-2-Amino-3-phenylpropanoic acid 1.55 2.5 4.2 2.1 2.59 0.99
7 Threonine(T) C₄H₉NO₃ 2-Amino-3-hydroxybutanoic acid 1.48 3.2 4.75 1.3 2.69 1.41
8 Tryptophan(W) C11H12N2O2 2-Amino-3-(1H-indol-3-yl)propanoic acid 3.94 1.2 1.3 NA 2.15 1.27
9 Valine(V) C5H11NO2 2-Amino-3-methylbutanoic acid 1.63 2.9 4.15 2.3 2.74 0.93
Conditionally Essential Amino Acid
10 Arginine ( R) C6H14N4O2 2-Amino-5-guanidinopentanoic acid  

1.9

 

3.8

 

4.85

 

2.2

 

3.18

 

1.20

11 Cysteine ( C) C3H7NO2S 2-Amino-3-sulfhydryl-propanoic acid 0.18 1.7 4.05 1.1 1.75 1.43
12 Glutamine( Q) C5H10N2O3 2,5-Diamino-5-oxopentanoic acid 7.06 NA NA NA 7.06 NA
13 Glycine (G) C2H5NO2 2-Aminoethanoic acid 1.2 3.0 5.35 2.0 2.88 1.56
14 Proline(P) C5H9NO2 Pyrrolidine-2-carboxylic acid 2.5 NA 5.6 6.1 4.73 1.59
15 Tyrosine(Y) C9H11NO3 L-2-Amino-3-(4-hydroxyphenyl)propanoic acid 0.78 2.3 3.05 4.2 2.58 1.24
Non-essential Amino Acid

 

16 Alanine (A) C3H7NO2 2-Aminopropanoic acid 2.4 5.4 5.7 5.8 4.84 1.41
17 Aspartic acid (D) C4H7NO4 2-Aminobutanedioic acid 3.14 7 NA 3.4 4.52 1.78
18 Asparagine (N) C4H8N2O3 2-Amino-3-carbamoylpropanoic acid NA NA 11.5 NA 11.35 NA
19 Glutamic Acid ( E) C5H9NO4 2-Aminoglutaric acid NA 6.5 19.05 5.6 10.39 6.13
20 Serine (S ) C3H7NO3 2-Amino-3-hydroxypropanoic acid 1.89 3.3 5.85 3.1 3.54 1.44

Table 5. Fatty acids content on Dry Weight basis of White Button Mushroom-mg/100g

Components Content
Total unsaturated fatty acids 79.72
Linoleic acid 67.29
Total saturated fatty acids 20.28
Palmitynic acid 13.35
Oleic acid 6.07
Palmitoleic acid 4.84
Stearic acid 3.72
Total lipids(%) 2.70
Linolenic acid 1.52
Caprylic acid 1.08
Miristic acid 0.94
Arachidic acid 0.92
Caprinic acid 0.85
Pentadecanoic acid 0.23
Laurnic acid 0.11

Table 6. Vitamins content  on Dry Weight basis of White Button Mushroom-mg/100g

Components Content
Vitamin C 17.00
Vitamin B1 0.60
Vitamin B2 5.10
Vitamin B3 43.00
Niacin 42.00
Folic acid (µg/100g) 450.00
Vitamin B12(µg/100g) 0.80
Vitamin D(µg/100g) 3.00

Table 7. Ergo sterol Compounds on Fresh Weight

basis of White Button Mushroom-g/100g

Components Content
Ergosterol 186.1
Ergosta.7.enol 1.73
Ergosta.5,7-dienol 6.05
Ergosta-7, 22 dienol 2.45

Table 8. Phenolic compounds content on Dry Weight Weight basis of White Button                               Dry Weight basis of White Button Mushroom Mushroom-g/100g-mg/Kg

Components Content
Total Phenols 277-687
Free Phenols 176-487
Myricetin 2729.46
Caffeic acid 392.51
Procatechuic acid 83.26
Catechins 56.74
Ferulic acid 42.83
Gallic acid 28.45
p-coumaric acid 2.31
Cinnamic acid 0.38

 

Table 9.Tocopherol   content on Dry Weight basis of White Button Mushroom-mg/100g

Components Content
α-Tocopherol 1-4
γ-Tocopherol 2-3
δ-Tocopherol 1.00

 

Table 10. Mineralscontents on Dry Weight Basis of White Button Mushroom-mg/Kg

Sr.No Se Ni P N Mn Fe Na Mg Cu Zn Ca K S
1 NA 29.5 NA NA 0.4779 NA NA 113.4 29.75 NA 58.25 3260 190.58
2 1.4 0.99 7490 NA 7.36 84.35 86 391 38.22 NA 159.375 NA NA
3 0.66 NA NA NA NA 29.3 326.6 NA 98 NA 22.6 4833 NA
4 0.15 0.778 17300 NA NA 400 860 2275 125 112.75 990 45200 NA
5 0.49 30.75 1300 80 45 350 19 100 698.5 81.6 12.3 NA NA
6 0.56 21 500 60 10 200 20 230 637 89.8 10.3 NA NA
7 0.093 NA 860 NA 0.48 5.0 50 90 NA 5.2 30 3180 NA
8 0.91 21.76 2923.3 71.33 7.54 151.66 20.33 195 117.7 79.2 51.98 3910 629.23
Average Mean 0.609 17.46 5062.2 70.44 11.808 174.33 197.4 484.9 249.2 73.71 166.851 12077 409.91
10 0.416 12.26 5956.2 8.189 15.275 141.81 289 737.2 267.2 36.246 314.355 16572 219.33

Table 11. Indole compounds content on Dr Weight basis of White Button Mushroom mg/100g

Components Contents
L -Tryptophan 0.39
Serotonin 5.21
Melatonin 0.11
Tryptoamaine 0.06
Kyruneric acid 6.21
Indole Acetic Acid 0.19

Table 12. General supportive treatments for Coronavirus

 

Nutritional interventions

 

Virus targeted and functions related
Combination of B1, B2, B3, B5, B6,

B7, B9 and B12 vitamins

 

MERS-CoV (Middle East respiratory syndrome coronavirus), ventilator induced lung injury
Ascorbic acid -C6H8O6(Vitamin C )

 

Avian coronavirus; lower respiratory tract infections
Ergocalciferol-C28H44O(Vitamin D

 

Bovine coronavirus
Vitamin E ( Tocopherol) Coxsackievirus, bovine coronavirus
Omega 3-polyunsaturated fatty acids Influenza virus, human immunodeficiency virus
Se Influenza virus, avian coronavirus; viral mutations
Zn Measles virus, SARS-CoV
Fe

 

Viral mutations
 

Intravenous gamma globulin

 

SARS-CoV(Severe Acute Respiratory Syndrome Corona Virus)

 

COVID-19 severe complications with respiratory illness to other diseases

Severe difficulties of influenza include respiratory failure, encephalopathy  pneumonia,  and seizures, and could grow from infection with other respiratory viruses [56, 89]. This virus own family is recognized to infect diverse animals and is also moreover regarded to mutate easily. Sometimes coronavirus types that infect animals (like; bats, civet cats, and camels) mutate to infect humans, and this may have lethal consequences. Worldwide, humans get unwell from the four types of coronavirus that cause milder infections on a day to day basis. But three types—those that reason SARS, MERS, and COVID-19 (SARS-CoV-2) can be fatal, and every of those has led to a foremost global outbreak[30, 83].The global coronavirus COVID-19 outbreak of 2020 was caused by the utmost transmissible anxiety of serious coronavirus yet. The WHO (World Health Organization) declared COVID-19 an outbreak pandemic disease on March 11. SARS-CoV-2 is that the virus that causes the disease COVID-19 may be potentially deadly breathing contamination that originated in Wuhan City, China in December 2019. COVID-19 mostly affect on to lung infections, human beings with those may experience cough and fever, together with shortness of breath. The affected by COVID-19 have been reports of patients with stomach problems like diarrhoea, vomiting and no sense of smell [11].

Is there a treatment?

There isn’t any specific antiviral treatment alternative for COVID-19, and no vaccine is presently available. The treatment is symptomatic, and oxygen treatment says to the very giant remedy for patients with extreme contamination. Mechanical aeration may also be crucial in times of breathing failure and unmanageable to oxygen remedy, at the same time as hemodynamic assistance is essential for dealing with septic shockwave. Long run complexities among overcomers of infection with SARS-CoV-2 having clinically huge COVID-19 sickness aren’t but accessible. Mechanical ventilation could be with decrease tidal volumes (4 to 6 ml/kg predicted body weight, PBW) and lower inspiratory weight, reaching a plateau pressure (Pplat) < 28 to 30 cm H2O. PEEP ought to be as excessive as achievable to keep up the using pressure (Pplat-PEEP) as low as should be predicted beneath the conditions (< 14 cmH2O). Based on currently available records and scientific medical expertise, following pills used for remedy underlying run medical trial for COVID-19 [12, Table 2].

White button mushroom and future scope for covid-19 treatment

Carbohydrate

These mushrooms comprise naturally very active polysaccharides that typically belong to the cluster of beta-glucans. Those elements rise host immune protection through activatingsupplement system, improving macrophagesand natural cytotoxickiller cellular characteristic. WBM contained digestible carbohydrates include of general sugar, fructose, mannitol and oligosaccharides like Trehalose and non-starch polysaccharides consisting of chitin and β-glucans[8, 16, 42, (Table 3)].Basidiomycota is known to provide healing traits which can be being recognized with its glucan and different polysaccharides. β-glucan own intimate of mixtures and appear to exert their anti-tumorigenic final results through enhancement of cellular immunity [86].WBM (Agaricus bisporus) possesses latent fitness benefits for boosting mucosal immunity. The nutritional intake of Agaricus bisporus substantially speeds up secretory immunoglobulin “A” secretion [39].

 

Amino acids

The steady important natural amino acid compound intake as a part of an oral food regimen is powerful in taking flight muscle catabolism, promoting muscle anabolism, and restoring immunological characteristic. Arginine found in WBM fruit bodies delays tumour boom, metastasis and incorporate as nutritional dietarysupplements for patients with  cancers [57]. Agaricus bisporus mushroom consists of all essential and non-essential amino acids. A majority of these amino acids are beneficial as a weight-reduction plan for the fitness and healing advantages [15, 33, 54-55, 74, Table 4).

Fatty acids

WBM contained higher PUFAs (Polyunsaturated fatty acids) and features as endogenous anti-bacterial, anti-parasitic, and anti-viral molecules [18-19]. PUFAs increase the anti-bacterial movements of synthetic antibiotics in opposition to drug-resistant bacteria [25]. There’s evidence to suggest that PUFAs can inactivate HIV (human immunodeficiency virus), an enveloped virus, and thus, is of advantage in AIDS (acquired immunodeficiency syndrome) [19, 58].

Agaricus bisporus is low in fat content material however they include a few important fatty acids [62, Table 5]. The whole quantum of fatty acids ranged from 180-5818 mg/kg dry matter in WBM. Linoleic acid may be very important for human fitness. They also help to reduce High Density Lipoprotein inside the blood. Unsaturated fatty acids which include linoleic acid and linolenic acid were proven to inhibit aromatase motion and subsequent reduction of estrogen using extracts of mushroom that helps to mechanism for influents on estrogen receptor revolutionary tumours [4, 67, 69].

 

Vitamins

2019 new coronavirus (2019-nCoV) inflamed pneumonia, namely severe acute respiratory tract infection (SARI) has triggered a global situation and emergency. Effective focused antiviral drugs are scarce, and symptomatic supportive treatment continues to be this main remedy. Vitamin C is very significant to the human body and plays an essential role in reducing the inflammatory response and preventing normal cold. Besides, a few researches have proven that diet vitamin C (ascorbic acid) deficiency is associated with the increased threat and severity of influenza infections [87].

WBM has considered a very decent supply of vitamins. It was mentioned that the foremost abundant nutrition content like a vitamin in Agaricus bisporus is Niacin, followed by vitamin B3, Vitamin C, folic acid, Vitamin B2, Vitamin B1, Vitamin D, and B12 fats-soluble diet such as vitamin [8,42,Table 6].

Mushrooms are natural source of Vitamins D and fat soluble  vitamin observed in large quantum in wild mushrooms in comparison to cultivated mushrooms.  For the fitness of bones vitamin D is very essential. Ergosterol might also be a biological precursor to dietary element vitamin D and is of fungal cellular membranes. It discovered with wide-ranges between 1.73 -186.1mg/100g do (desk 7). Ergosterol is correlated with their antioxidant activities [70-71].

 

Phenolic Compounds

The phenolic and antioxidant properties of WBM have stated with the aid of many authors [6, 13, 50, 66]. Phenolic compounds are reported due to the fact of very important antioxidant components in mushroom (Table 8). As an herbal phenolic compound Gallic acid is observed in numerous herbal and medicinal plants. It’s possess numerous health benefits to treatment of various disorder like HIV-1 integrase, transcriptase, protease dimerization, HCV, and HSV attachment and penetration.

Gallic acid plays very significant role in Haemophilus influenza A and B debris [35, 45, 46, 91]. Phenolic acids are precise vital compounds that originate within the plant domain through specific structural similarities, presence of carboxylic group. The various beneficial acids reported in mushroom. The recommended dose of (PCA) proto-catechuic acid, caffeic acid, Gallic acid and (PC) p-coumaric acid are 100 mg per kg of body weight. These compound work as very powerful anti-inflammatory, antioxidant, antihyperlipidemic antibacterial, anticancer, and antidiabetic[41, 68].

Tocopherol

Tocopherol (TCP) is fat-soluble antioxidants however also seem to possess other functions inside the fruit body. In WBM three forms of tocopherol found (Table 9). Alpha-tocopherol is that the type of nutrition vitamin E that is fat-soluble vitamin preferentially absorbed and stored in humans [66]. As a food- additive, tocopherol is labelled with these E numbers: E306 (tocopherol), E307 (α-tocopherol), E308 (γ-tocopherol), and E309 (δ-tocopherol) [76].

Minerals content

WBMs are recognized to be a superb accumulator of minerals from the environment wherein they grow [5, 9, 54, 61, 64-65, 72-73, 80]. Agaricus bisporus may be a noble source of K, Fe, Zn, Cu, Ca, Na, Se, Mn and Mg (Table 10).WBM fruiting bodies often provide an enormous quantum of absorbable minerals ingredients. Agaricus bisporus fruiting bodies are often suggested to supplement the diet with all the minerals which can be vital for health.WBM showed that there has been excessive content of those elements in fruiting bodies, which may be used as nutraceuticals [26].

The lack of zinc in baby causes lower respiratory tract respiration infections and also effect on measles associated morbidity and mortality. The supplementation of pyrithione zinc ionophores via intracellular properly weaken the replication of RNA viruses.In some instances the treatment for SARS-CoV, the inclusive of zinc and pyrithione at low quantum found very powerful impact [3].Consequently, zinc dietary supplements may have an impact on COVID-19 related signs and symptoms like diarrhoea and lower breathing tract breathing infection but additionally on COVID-19 itself.

Indole Compounds

In WBM Indole compounds present in the form of L-tryptophan, Kynurenic acid, and other compounds [31,Table 11].The most general causes of acute liver failure are drug- triggered liver damage , virus infection, and autoimmune diseases [13,32,47]. The utilization of KYNA as a replacement of a prophylactic or therapeutic approach for the remedy of ALF needs to be considered. Moreover, since KYNA may be a constituent of food existing during a considerably high amount in designated products the use of diet containing high KYNA or KYNA-enriched supplements seems to be reasonable, especially in subjects with a high risk of ALF [23]. Therefore Indole compounds are also useful for the treatment of COVID-19.

Conclusion

WBM (Agaricus bisporus) might also provide sizable support towards COVID- 19 because of high nutritional and medicinal properties. Consumption of WBM isn’t beneficial just in case of nourishment but also existing as anticancer, anti-cardiovascular diseases,ant diabetes, antioxidant and antimicrobial. In earlier decades, the edible mushroom has remained used as a foundation of treatment. Most of the investigation has proven that nutraceutical therapy may be a promising source of recent therapeutics against COVID-19 diseases. Furthermore, vitamins B treatment drastically withdrawn neutrophil intrusion into the lungs with an effective  anti-inflammatory impact in the way of the ventilator induced lung damage. As scarcity of vitamins B may additionally weaken host immune response, they need to be supplemented to the virus- infected sufferers to enhance their immune  system[41].The nutritional  deficiency  impacts  no longer only on the immune response, but moreover  the viral pathogen itself. The selenium deficiency in body causes oxidative stress within the host and can regulate a viral genome order that a typically benevolent or slightly pathogenic virus can emerge as exceedingly virulent inside the poor host [24, 37].11The reaction (immune)has often been confirmed to be weakened by using inadequate nutrients in many model systems similarly to human research. However ,the nutritional position of the host, till currently, has no longer been considered as contributing component to the emergence of viral infectious sicknesses. Consequently,to confirm the nutritional property of coronavirus disease (COVID-19) infected patient’s  earlier than the administration of popular treatments. Besides, additionally discovered  that coronavirus disease precise treatments and against viral remedies had been very useful forthe remedy of SARS and MERS. Therefore, might be considered as potential treatments for coronavirus disease infection [88, Table 12].

Nutritional l defi-ciency impacts not only the immune response but also the viralpathogen itself.10Dietary selenium deficiency that causes oxida-tive stress in the host can alter a viral genome so that a normallythe benign or mildly pathogenic virus can become highly virulent in thedeficient host under oxidative stress.The immune response has often been shown to beweakened by inadequate nutrition in many model systems as well as in human studies. However, the nutritional status of the host, until recently, has not been considered as a contributing factor to the emergence of viral infectious diseases. Therefore, we propose to verify the nutritional status of COVID‐19 infected patients before the administration of general treatments. Besides, we also found coronavirus‐specific treatments and antiviral treatments were very useful for the treatment of SARS and MERS. They should also be considered as potential treatments for COVID‐19 infection Although bioactive molecules present in WBM may additionally constitute an important advance for their characterization as a source of medicine, more clinical statistics data are needed for the medicinal benefits of COVID-19.

Acknowledgements

I am grateful to the Dr. Arun Mishra for providing support to conduct academic research at SGVU, Jaipur, and Rajasthan, India. I also thank to the principal Prof. (Dr.) Sushil Kumar Sharma, Dr. Mukesh Kumar Gupta and Management of SGVU for continuous support and motivation during the work for providing facility and support during manuscript preparation.

Conflicts of interest

The authors declare that they have no conflict of interest.

References

  1. Arbour, N., Day, R., Newcombe, J., & Talbot, P. J. (2000). Neuroinvasion by human respiratory coronaviruses. Journal of virology, 74(19), 8913-8921.
  2. Arbour, N., Ekandé, S., Côté, G., Lachance, C., Chagnon, F., Tardieu, M. & Talbot, P. J. (1999). Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. Journal of virology, 73(4), 3326-3337.
  3. Awotiwon, A. A., Oduwole, O., Sinha, A., & Okwundu, C. I. (2017). Zinc supplementation for the treatment of measles in children. Cochrane Database of Systematic Reviews, (6).
  4. Baars, J. J. P., Sonnenberg, A. S. M., Mumm, R., Stijger, I., & Wehrens, H. R. M. J. (2016). Metabolites contributing to taste in Agaricus bisporus (No. 2016-1). Plant Research International.
  5. Bąkowski, J., Szudyga, K., Horbowicz, M., & Czapski, J. (1986). The influence of compost on carbohydrates and minerals contained in the mushrooms (Agaricus bisporus). Acta agrobotanica, 39(1), 85-97.
  6. Barros, L., Falcão, S., Baptista, P., Freire, C., Vilas-Boas, M., & Ferreira, I. C. (2008). Antioxidant activity of Agaricus sp. mushrooms by chemical, biochemical and electrochemical assays. Food Chemistry, 111(1), 61-66.
  7. Bernardshaw, S., Hetland, G., Ellertsen, L. K., Tryggestad, A. M. A., & Johnson, E. (2005). An extract of the medicinal mushroom Agaricus blazei Murill differentially stimulates the production of pro-inflammatory cytokines in human monocytes and human vein endothelial cells in vitro. Inflammation, 29(4-6), 147-153.
  8. Bernaś, E., Jaworska, G., & Lisiewska, Z. (2006). Edible mushrooms as a source of valuable nutritive constituents. Acta Scientiarum Polonorum Technologia Alimentaria, 5(1), 5-20.
  9. Bhushan, A., & Kulshreshtha, M. 2018. The medicinal Mushroom Agaricus bisporus: Review of phytopharmacology and potential role in the treatment of various diseases. Journal of Nature and Science of Medicine, 1(1), 4.
  10. Bruggemann, R., Matsuo Orlandi, J., Benati, F. J., Faccin, L. C., Mantovani, M. S., Nozawa, C., & Linhares, R. E. C. (2006). Antiviral activity of Agaricus blazei Murrill ss. Heinem extracts against human and bovine herpesviruses in cell culture. Brazilian Journal of Microbiology, 37(4), 561-565.
  11. Burke, R. M. (2020). Active monitoring of persons exposed to patients with confirmed COVID-19—United States, January–February 2020. MMWR. Morbidity and Mortality Weekly Report, 69.
  12. Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). In StatPearls [Internet]. StatPearls Publishing.
  13. Chang, C. Y., & Schiano, T. D. (2007). Drug hepatotoxicity. Alimentary pharmacology & therapeutics, 25(10), 1135-1151.
  14. Chen, S., Phung, S., Hur, G., Kwok, S., Ye, J., & Oh, S. R. (2005). Breast cancer prevention with phytochemicals in mushrooms.Proc Amer Assoc Cancer Res, Volume 46, 2005; 5186.
  15. Cherno, N., Osolina, S., & Nikitina, A. (2016). Chemical Composition of Agaricus Bisporus and Pleurotus Ostreatus Fruiting Bodies and Their Morphological Parts. Food and Environment Safety Journal, 12(4).
  16. Cheung, P. C. K. (2010). The nutritional and health benefits of mushrooms. Nutrition Bulletin, 35(4), 292-299.
  17. de Sousa Cardozo, F. T. G., Camelini, C. M., Mascarello, A., Rossi, M. J., Nunes, R. J., Barardi, C. R. M., & Simões, C. M. O. (2011). The anti-herpetic activity of a sulphated polysaccharide from Agaricus brasiliensis mycelia. Antiviral Research, 92(1), 108-114.
  18. Das, U. N. (1985). Antibiotic-like action of essential fatty acids. Canadian Medical Association Journal, 132(12), 1350.
  19. Das, U. N. (2006). Do unsaturated fatty acids function as endogenous antibacterial and antiviral molecules? The American journal of clinical nutrition, 83(2), 390-391.
  20. Ellertsen, L. K., & Hetland, G. (2009). An extract of the medicinal mushroom Agaricus blazei Murill can protect against allergy. Clinical and Molecular Allergy, 7(1), 6.
  21. Firenzuoli, F., Gori, L., & Lombardo, G. (2008). The medicinal mushroom Agaricus blazei Murrill: a review of the literature and pharmaco-toxicological problems. Evidence-Based Complementary and Alternative Medicine, 5(1), 3-15.
  22. Førland, D. T., Johnson, E., Saetre, L., Lyberg, T., Lygren, I., & Hetland, G. (2011). Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on the expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn’s disease. Scandinavian Journal of Immunology, 73(1), 66-75.
  23. Fernstrom, J. D. (2016). A perspective on the safety of supplemental tryptophan based on its metabolic fates. The Journal of nutrition, 146(12), 2601S-2608S.
  24. Guillin, O. M., Vindry, C., Ohlmann, T., & Chavatte, L. (2019). Selenium, selenoproteins and viral infection. Nutrients, 11(9), 2101.
  25. Giamarellos-Bourboulis, E. J., Mouktaroudi, M., Adamis, T., Koussoulas, V., Baziaka, F., Perrea, D., & Giamarellou, H. (2004). n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 48(12), 4713-4717.
  26. Golak-Siwulska, I., Kałużewicz, A., Wdowienko, S., Dawidowicz, L., & Sobieralski, K. (2018). Nutritional value and health-promoting properties of Agaricus bisporus (Lange) Imbach. Herba Polonica, 64(4), 71-81.
  27. Gorbalenya, A. E., Snijder, E. J., & Spaan, W. J. (2004). Severe acute respiratory syndrome coronavirus phylogeny: toward consensus. Journal of virology, 78(15), 7863-7866.
  28. Gorse, G. J., O’Connor, T. Z., Hall, S. L., Vitale, J. N., & Nichol, K. L. (2009). Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease. The Journal of infectious diseases, 199(6), 847-857.
  29. Graham, R. L., Donaldson, E. F., & Baric, R. S. (2013). A decade after SARS: strategies for controlling emerging coronaviruses. Nature Reviews Microbiology, 11(12), 836-848.
  30. Guarner, J. (2020). Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19.
  31. Holtze, M., Mickiene, A., Atlas, A., Lindquist, L., & Schwieler, L. (2012). Elevated cerebrospinal fluid kynurenic acid levels in patients with tick borne encephalitis. Journal of internal medicine, 272(4), 394-401.
  32. Harvala, H., Wong, V., Simmonds, P., Johannessen, I., & Ramalingam, S. (2014). Acute viral hepatitis–Should the current screening strategy be modified? Journal of Clinical Virology, 59(3), 184-187.
  33. Hayes, W. A. (1976). The food value of the cultivated mushroom and its importance to the mushroom industry. Mushroom J., 40, 104-110.
  34. Hetland, G., Johnson, E., Lyberg, T., & Kvalheim, G. (2011). The mushroom Agaricus blazei Murill elicits medicinal effects on the tumor, infection, allergy, and inflammation through its modulation of innate immunity and amelioration of Th1/Th2 imbalance and inflammation. Advances in pharmacological sciences, 2011.
  35. Hsu, W. C., Chang, S. P., Lin, L. C., Li, C. L., Richardson, C. D., Lin, C. C., & Lin, L. T. (2015). Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry. Antiviral Research, 118, 139-147.
  36. Hu, B., Ge, X., Wang, L. F., & Shi, Z. (2015). Bat origin of human coronaviruses. Virology journal, 12(1), 221.
  37. Jones, H. D., Yoo, J., Crother, T. R., Kyme, P., Ben-Shlomo, A., Khalafi, R. … & Shimada, K. (2015). Nicotinamide exacerbates hypoxemia in ventilator-induced lung injury independent of neutrophil infiltration. PloS one, 10(4).
  38. Jacomy, H., Fragoso, G., Almazan, G., Mushynski, W. E., & Talbot, P. J. (2006). Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology, 349(2), 335-346.
  39. Jeong, S. C., Koyyalamudi, S. R., & Pang, G. (2012). Dietary intake of Agaricus bisporus white button mushroom accelerates salivary immunoglobulin a secretion in healthy volunteers. Nutrition, 28(5), 527-531.
  40. Jones, B. A., Grace, D., Kock, R., Alonso, S., Rushton, J., Said, M. Y. … & Pfeiffer, D. U. (2013). Zoonosis emergence linked to agricultural intensification and environmental change. Proceedings of the National Academy of Sciences, 110(21), 8399-8404.
  41. Kakkar, S., & Bais, S. (2014). A review of protocatechuic acid and its pharmacological potential. ISRN Pharmacology, 2014.
  42. Kalbarczyk, J., & Radzki, W. (2009). Cultivated mushrooms as a valuable diet constituent and a source of biologically active substances. Herba Polonica, 55(4), 224-232.
  43. Kent, D., Sheridan, C., Tomkinson, H. A., White, S., Hiscott, P., & Grierson, I. (2003). Edible mushroom (Agaricus bisporus) lectin modulates human retinal pigment epithelial cell behavior in vitro. Experimental eye research, 76(2), 213-219.
  44. Kim, Y., Cheon, S., Min, C. K., Sohn, K. M., Kang, Y. J., Cha, Y. J., & Aigerim, A. (2016). Spread of mutant Middle East respiratory syndrome coronavirus with reduced affinity to human CD26 during the South Korean outbreak. MBio, 7(2), e00019-16.
  45. Kratz, J. M., Andrighetti-Fröhner, C. R., Kolling, D. J., Leal, P. C., Cirne-Santos, C. C., Yunes, R. A., and Barardi, C. R. M. (2008). Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Memorias do Instituto Oswaldo Cruz, 103(5), 437-442.
  46. Lee, J. H., Oh, M., Seok, J. H., Kim, S., Lee, D. B., Bae, G. & Lee, D. H. (2016). Antiviral effects of black raspberry (Rubus coreanus) seed and its gallic acid against influenza virus infection. Viruses, 8(6), 157.
  47. Li, J., Zhu, X., Liu, F., Cai, P., Sanders, C., Lee, W. M., & Uetrecht, J. (2010). Cytokine and autoantibody patterns in acute liver failure. Journal of immunotoxicology, 7(3), 157-164.
  48. Liu, Y., Fukuwatari, Y., Okumura, K., Takeda, K., Ishibashi, K. I., Furukawa, M. & Motoi, M. (2008). Immunomodulating activity of Agaricus brasiliensis KA21 in mice and human volunteers. Evidence-Based Complementary and Alternative Medicine, 5(2), 205-219.
  49. Lin, J. G., Fan, M. J., Tang, N. Y., Yang, J. S., Hsia, T. C., Lin, J. J., & Chung, J. G. (2012). An extract of Agaricus blazei Murill administered orally promotes immune responses in murine leukaemia BALB/c mice in vivo. Integrative cancer therapies, 11(1), 29-36.
  50. Maares, M., & Haase, H. (2016). Zinc and immunity: An essential interrelation. Archives of biochemistry and biophysics, 611, 58-65.
  51. Masters P.S. (2006). The Molecular Biology of Coronaviruses Advances in Virus Research. Volume 66. Academic Press; Massachusetts, MA, USA, pp. 193–292.
  52. McBride, R., & Fielding, B. C. (2012). The role of the severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis. Viruses, 4(11), 2902-2923.
  53. Mizuno, T., & Zhuang, C. (1995). Maitake, Grifola frondosa: pharmacological effects. Food Reviews International, 11(1), 135-149.
  54. Muszyńska, B., Krakowska, A., Sułkowska-Ziaja, K., Opoka, W., Reczyński, W., & Baś, B. (2015). In vitro cultures and fruiting bodies of culinary-medicinal Agaricus bisporus (white button mushroom) as a source of selected biologically-active elements. Journal of Food Science and Technology, 52(11), 7337-7344.
  55. Muszyńska, B., Kała, K., Rojowski, J., Grzywacz, A., & Opoka, W. (2017). Composition and biological properties of Agaricus bisporus fruiting bodies–a review. Polish Journal of Food and Nutrition Sciences, 67(3), 173-182.
  56. Newland, J. G., Laurich, V. M., Rosenquist, A. W., Heydon, K., Licht, D. J., Keren, R., … & Coffin, S. E. (2007). Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. The Journal of pediatrics, 150(3), 306-310.
  57. Novaes, M. R. C. G., Valadares, F., Reis, M. C., Gonçalves, D. R., & Menezes, M. D. C. (2011). The effects of dietary supplementation with Agaricales mushrooms and other medicinal fungi on breast cancer: evidence-based medicine. Clinics, 66(12), 2133-2139.
  58. Nutan, M. M., Goel, T., Das, T., Malik, S., Suri, S., Rawat, A. K. S. & Gupta, S. K. (2013). Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease & reverse transcriptase activity. The Indian journal of medical research, 137(3), 540.
  59. Oboho, I. K., Tomczyk, S. M., Al-Asmari, A. M., Banjar, A. A., Al-Mugti, H., Aloraini, M. S., & Swerdlow, D. L. (2015). 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. New England Journal of Medicine, 372(9), 846-854.
  60. Oh, T. W., Kim, Y. A., Jang, W. J., Byeon, J. I., Ryu, C. H., Kim, J. O., & Ha, Y. L. (2010). Semi purified fractions from the submerged-culture broth of Agaricus blazei Murill reduce blood glucose levels in streptozotocin-induced diabetic rats. Journal of agricultural and food chemistry, 58(7), 4113-4119.
  61. Owaid, M. N., & Ibraheem, I. J. (2017). Mycosynthesis of nanoparticles using edible and medicinal mushrooms. European Journal of Nanomedicine, 9(1), 5-23.
  62. Öztürk, M., Duru, M. E., Kivrak, Ş., Mercan-Doğan, N., Türkoglu, A., & Özler, M. A. (2011). In vitro antioxidant, anticholinesterase and antimicrobial activity studies on three Agaricus species with fatty acid compositions and iron contents: A comparative study on the three most edible mushrooms. Food and Chemical Toxicology, 49(6), 1353-1360.
  63. Pene, F., Merlat, A., Vabret, A., Rozenberg, F., Buzyn, A., Dreyfus, F & Lebon, P. (2003). Coronavirus 229E-related pneumonia in immunocompromised patients. Clinical infectious diseases, 37(7), 929-932.
  64. Poongkodi, G. K., & Priya, G. (2015). Nutrient contents of edible mushrooms, Agaricus bisporus and Pleurotus ostreatus. International Journal of Modern Chemistry and Applied Science, 2(2), 78-86.
  65. Poongkodi, G. K., Harithra Priya, G. P., & Harshitha Priya, G. P. 2015. Nutrient contents of edible mushrooms, Agaricus bisporus and Pleurotus ostreatus. Int J Mod Chem Appl Sci, 2(2), 78-86.
  66. Rigotti A (2007). “Absorption, transport, and tissue delivery of vitamin E”. Molecular Aspects of Medicine. 28 (5–6): 423–36.
  67. Roupas, P., Keogh, J., Noakes, M., Margetts, C., & Taylor, P. (2012). The role of edible mushrooms in health: Evaluation of the evidence. Journal of Functional Foods, 4(4), 687-709.
  68. Robbins, R. J. (2003). Phenolic acids in foods: an overview of analytical methodology. Journal of agricultural and food chemistry, 51(10), 2866-2887.
  69. Saiqa, S., Haq, N. B., Muhammad, A. H., Muhammad, A. A., & ATA, U. R. (2008). Studies on chemical composition and nutritive evaluation of wild edible mushrooms.
  70. Shao, S., Hernandez, M., Kramer, J. K., Rinker, D. L., & Tsao, R. (2010). Ergosterol profiles, fatty acid composition, and antioxidant activities of button mushrooms as affected by tissue part and developmental stage. Journal of agricultural and food chemistry, 58(22), 11616-11625.
  71. Simon, R. R., Phillips, K. M., Horst, R. L., & Munro, I. C. (2011). Vitamin D mushrooms: comparison of the composition of button mushrooms (Agaricus bisporus) treated postharvest with UVB light or sunlight. Journal of agricultural and food chemistry, 59(16), 8724-8732.
  72. Sinha, S.K; Upadhaya, T.K; Sharma, S.K and Sharma Manju, (2020).Nutritional and Medicinal profile of white button mushroom cultivated in Maharashtra, India: 5th Global outreach conference on modern approaches for smart agriculture (MASA-2020).P87.
  73. Stamets, P. E. 2005. Notes on nutritional properties of culinary-medicinal mushrooms. International Journal of Medicinal Mushrooms, 7(1&2).
  74. Sudheep, N. M., & Sridhar, K. R. (2014). Nutritional composition of two wild mushrooms consumed by the tribals of the Western Ghats of India. Mycology, 5(2), 64-72.
  75. Turkoglu, A., Duru, M. E., Mercan, N., Kivrak, I., & Gezer, K. (2007). Antioxidant and antimicrobial activities of Laetiporus sulphureus (Bull.) Murrill. Food Chemistry, 101(1), 267-273.
  76. USFDA- US Food and Drug Administration. (2011). Listing of food additives status part II. Retrieved Oct.
  77. Valadares, D. G., Duarte, M. C., Oliveira, J. S., Chávez-Fumagalli, M. A., Martins, V. T., Costa, L. E., & Coelho, E. A. (2011). The leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species. Parasitology International, 60(4), 357-363.
  78. Valadares, D. G., Duarte, M. C., Ramírez, L., Chávez-Fumagalli, M. A., Martins, V. T., Costa, L. E., … & Régis, W. C. (2012). Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in the treatment of murine visceral leishmaniasis. Experimental parasitology, 132(2), 228-236.
  79. Van der Hoek, L. (2007). Human coronaviruses: what do they cause? Antiviral therapy, 12(4 Pt B), 651.
  80. Vetter, J. 2003. Chemical composition of fresh and conserved Agaricus bisporus mushroom. European Food Research and Technology, 217(1), 10-12.
  81. Vijgen, L., Keyaerts, E., Moës, E., Maes, P., Duson, G., & Van Ranst, M. (2005). Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E. Journal of clinical microbiology, 43(11), 5452-5456.
  82. Walsh, E. E., Shin, J. H., & Falsey, A. R. (2013). Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. The Journal of infectious diseases, 208(10), 1634-1642.
  83. Wang, M., Yan, M., Xu, H., Liang, W., Kan, B., Zheng, B. & Wang, H. (2005). SARS-CoV infection in a restaurant from palm civet. Emerging infectious diseases, 11(12), 1860.
  84. Winer, E. P., Hudis, C., Burstein, H. J., Chlebowski, R. T., Ingle, J. N., Edge, S. B. & Braun, S. (2002). American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: Status report 2002. Journal of Clinical Oncology, 20(15), 3317-3327.
  85. Yang, J. S., Park, S., Kim, Y. J., Kang, H. J., Kim, H., Han, Y. W. & Kim, J. A. (2015). Middle Ea[i]st respiratory syndrome in 3 persons, South Korea, 2015. Emerging infectious diseases, 21(11), 2084.
  86. Zhang, J., Ma, Z., Zheng, L., Zhai, G., Wang, L., Jia, M., & Jia, L. (2014). Purification and antioxidant activities of intracellular zinc polysaccharides from Pleurotus cornucopiae SS-03. Carbohydrate polymers, 111, 947-954.
  87. Zhang, L. (2010). Get the latest public health information from CDC: https://www. coronavirus. gov Get the latest research information from NIH: https://www. nih. gov/coronavirus.
  88. Zhang, L., & Liu, Y. (2020). Potential interventions for novel coronavirus in China: a systemic review. Journal of medical virology.
  89. Zhou, H., Thompson, W. W., Viboud, C. G., Ringholz, C. M., Cheng, P. Y., Steiner, C. & Shay, D. K. (2012). Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clinical infectious diseases, 54(10), 1427-1436.
  90. Zhu, W., Chiu, L. C. M., Ooi, V. E. C., Chan, P. K. S., & Ang Jr, P. O. (2004). Antiviral property and mode of action of a sulphated polysaccharide from Sargassum patens against herpes simplex virus type 2. International journal of antimicrobial agents, 24(3), 279-283.Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J. & Niu, P. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine.
  91. Zuo, G. Y., Li, Z. Q., Chen, L. R., & Xu, X. J. (2005). In vitro anti-HCV activities of Saxifraga melanocentra and its related polyphenolic compounds. Antiviral Chemistry and Chemotherapy, 16(6), 393-398[ii].